Knowledge, attitude, practice, and barriers among physicians in the Middle East and North Africa region toward influenza vaccination for the high-risk group of patients: a cross-sectional study

被引：0
作者：
Saadi M. Saleh [1 ]
Alaa Aljamala [1 ]
Dina Hafez [2 ]
Mosab Abu Shqeer [3 ]
Islam Abukandil [4 ]
Weam Aldiban [5 ]
Azza Baraka [6 ]
机构：
[1] Faculty of Medicine, Benha University, Benha
[2] Pharmacy Department, Alexandria University Students Hospital, Alexandria
[3] Faculty of Medicine, Hashemite University, Zarqa
[4] Faculty of Medicine, Alexandria University, Alexandria
[5] Faculty of Pharmacy, International University for Science and Technology (IUST), Daraa
[6] Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, Alexandria
来源：
Tropical Diseases, Travel Medicine and Vaccines | / 11卷 / 1期
关键词：
Attitudes; Barriers; High-risk; Influenza vaccines; Knowledge; Middle East; North Africa; Physicians; Practice;
D O I：
10.1186/s40794-024-00241-0
中图分类号：
学科分类号：
摘要：
Background: The influenza vaccine is a cost-effective measure to reduce morbidity and mortality, especially for high-risk patients. Healthcare providers have an essential role in patients’ education about vaccines. This study aims to examine physicians' understanding, perceptions, and practices regarding influenza vaccination in the Middle East and North Africa (MENA) region for high-risk patients. Methods: We conducted a multinational cross-sectional study in 21 countries in MENA region from July 10th to September 10th, 2023. Data were collected using an online self-administered survey distributed through different social media platforms. We used a valid questionnaire designed to determine the knowledge, attitude, and practice of physicians toward influenza vaccination. A multivariable binomial logistic regression analysis was conducted to identify significant predictors for offering the influenza vaccine. Results: In this study, which involved 2017 physicians (the mean (SD) age was 29 (± 6.2); 52% were males), the majority expressed a low to medium level of knowledge about influenza vaccination, with only 4% displaying a high level of knowledge. Regarding attitude, the majority (n = 1511, 74.9%) were quite concerned. However, only (n = 509, 25.4%) offered the vaccine to patients. The main predictors for offering the vaccine were age (adjusted odd ratio (AOR) = 1.036, 95%CI = 1.003–1.07, p = 0.031), male sex (AOR = 1.39, 95%CI = 1.09–1.77, p = 0.007), living in upper-middle-income countries (AOR = 3.14, 95%CI = 2.1–4.7, p < 0.001), having PhD degree (AOR = 3.15, 95%CI = 1.47–6.71, p = 0.003), being a senior resident (AOR = 2.005, 95%CI = 1.147–3.5, p = 0.015), working two to five shifts per week (AOR = 1.55, 95%CI = 1.02–2.35, p = 0.04), working more than five shifts per week (AOR = 1.75, 95%CI = 1.06- 2.88, p = 0.027), attitude (AOR = 1.33, 95%CI = 1.243- 1.44, p < 0.001), following these practices regarding influenz vaccination with the other office staff: Encourage and offer (AOR = 5.73, 95%CI = 4.11- 8.007, p < 0.001), require but do not offer (AOR = 3.73, 95%CI = 2.59- 5.38, p < 0.001), and require and offer the influenza vaccine (AOR = 6.79, 95%CI = 4.88- 9.45, p < 0.001) to the office staff. The main barriers to influenza vaccination were unawareness of vaccine availability (32%), cost (25%), and forgetfulness (23.4%). Conclusions: Approximately half of the physicians were knowledgeable about the flu vaccine, but practice was deficient and impeded by barriers like unawareness and forgetfulness. © The Author(s) 2025.
引用
收藏
相关论文
共 32 条
  • [1] Macias A.E., Mcelhaney J.E., Chaves S.S., Nealon J., Nunes M.C., Samson S.I., Et al., The disease burden of influenza beyond respiratory illness, vaccine, 39, pp. a6-a14, (2020)
  • [2] Peteranderl C., Herold S., Schmoldt C., Human Influenza Virus Infections, Seminars in Respiratory and Critical Care Medicine, 37, (2016)
  • [3] Michelozzi P., De D.F., Scortichini M., De S.M., Asta F., Agabiti N., On the increase in mortality in Italy in 2015: analysis of seasonal mortality in the 32 municipalities included in the Surveillance system of daily mortality, Epidemiol Prev, 40, 1, pp. 22-28, (2016)
  • [4] Froggatt H.M., Heaton N.S., Nonrespiratory sites of influenza-associated disease: Mechanisms and experimental systems for continued study, FEBS J, 289, 14, pp. 4038-4060, (2022)
  • [5] Hwang S., Lee H., Jung M., Kim S., Sung H.K., Oh M., Et al., Incidence, Severity, and Mortality of Influenza During 2010–2020 in Korea : A Nationwide Study Based on the Population-Based National Health Insurance Service Database, J Korean Med Sci, 38, 8, (2023)
  • [6] Beck C.R., Mckenzie B.C., Hashim A.B., Harris R.C., In N., In fl uenza Vaccination for Immunocompromised Patients : Systematic Review and Meta-analysis by Etiology, JID, (2012)
  • [7] Restivo V., Costantino C., Bono S., Maniglia M., Marchese V., Ventura G., Et al., In fl uenza vaccine effectiveness among high-risk groups : A systematic literature review and meta-analysis of case-control and cohort studies, Hum Vaccin Immunother, 14, 3, pp. 724-735, (2018)
  • [8] Trombetta C.M., Kistner O., Montomoli E., Viviani S., Marchi S., Influenza Viruses and Vaccines : The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines, Vaccines, 10, (2022)
  • [9] Arghittu A., Dettori M., Azara A., Gentili D., Serra A., Contu B., Et al., Flu Vaccination Attitudes, Behaviours, and Knowledge among Health Workers, Int J Environ Res Public Health, 17, (2020)
  • [10] Mardani M., Maltezou H., Nourlil J., Oumzil H., Osterhaus A., Influenza vaccination situation in Middle-East and North Africa countries: Report of the 7th MENA Influenza Stakeholders Network (MENA-ISN), J Infect Public Health, 11, 6, pp. 845-850, (2018)
1234